US Stock MarketDetailed Quotes

Teva Pharmaceutical Industries (TEVA)

Watchlist
  • 34.950
  • -0.120-0.34%
Close May 1 15:59 ET
  • 34.520
  • -0.430-1.23%
Post 20:01 ET
40.70BMarket Cap26.08P/E (TTM)

Teva Pharmaceutical Industries (TEVA) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
61.90%-40M
32.24%1.65B
101.39%1.16B
-46.68%369M
118.27%227M
15.32%-105M
-8.85%1.25B
-51.44%575M
13,740.00%692M
-67.90%104M
Net income from continuing operations
67.73%369M
172.38%1.42B
274.91%481M
211.28%434M
132.38%283M
152.51%220M
-218.54%-1.96B
-158.89%-275M
-606.49%-390M
3.53%-874M
Operating gains losses
-500.00%-8M
----
----
----
-100.00%-2M
--2M
46.34%-22M
--0
-600.00%-21M
96.67%-1M
Depreciation and amortization
-2.05%239M
-5.38%1B
-3.35%260M
-3.86%249M
-3.09%251M
-10.29%244M
-8.15%1.06B
1.13%269M
-8.48%259M
-13.67%259M
Deferred tax
-178.57%-22M
-5.84%-671M
-1,959.38%-595M
301.89%107M
50.24%-211M
114.81%28M
-100.00%-634M
0.00%32M
73.37%-53M
-863.64%-424M
Other non cash items
-440.00%-54M
-85.54%81M
-10.81%-41M
800.00%27M
-82.23%105M
-600.00%-10M
818.03%560M
-186.05%-37M
160.00%3M
5,025.00%591M
Change In working capital
11.86%-617M
-214.02%-1.37B
193.47%229M
-276.97%-561M
-3,260.00%-336M
-40.85%-700M
-504.17%-435M
-183.90%-245M
239.65%317M
-104.72%-10M
-Change in receivables
----
-170.61%-173M
----
----
----
----
1,941.67%245M
----
----
----
-Change in inventory
----
-8.43%152M
----
----
----
----
212.93%166M
----
----
----
-Change in payables and accrued expense
----
-105.81%-15M
----
----
----
----
-83.75%258M
----
----
----
-Change in other current assets
----
-20.47%-1.33B
----
----
----
----
27.61%-1.1B
----
----
----
Cash from discontinued investing activities
Operating cash flow
61.90%-40M
32.24%1.65B
101.39%1.16B
-46.75%369M
120.39%227M
15.32%-105M
-8.85%1.25B
-51.44%575M
13,760.00%693M
-68.21%103M
Investing cash flow
Cash flow from continuing investing activities
13.93%229M
-6.94%737M
-18.32%165M
-49.63%135M
32.58%236M
39.58%201M
-18.18%792M
-32.89%202M
45.65%268M
-41.06%178M
Net PPE purchase and sale
-32.28%-168M
-0.60%-501M
-10.08%-142M
8.11%-136M
1.03%-96M
-2.42%-127M
5.32%-498M
-8.40%-129M
0.67%-148M
18.49%-97M
Net business purchase and sale
147.06%42M
21.43%34M
--0
-78.95%8M
800.00%9M
213.33%17M
-58.82%28M
--4M
280.00%38M
-98.21%1M
Net investment purchase and sale
--0
51.61%-15M
266.67%25M
-133.33%-13M
62.79%-16M
8.33%-11M
32.61%-31M
-650.00%-15M
202.63%39M
-2,050.00%-43M
Net other investing changes
--1M
150.00%5M
--0
--2M
--3M
----
140.00%2M
----
----
----
Cash from discontinued investing activities
Investing cash flow
13.93%229M
-6.94%737M
-18.32%165M
-49.63%135M
32.58%236M
39.58%201M
-18.18%792M
-32.89%202M
45.65%268M
-41.06%178M
Financing cash flow
Cash flow from continuing financing activities
100.75%13M
-20.10%-2.15B
105.93%40M
-453M
100.62%6M
-1,054.30%-1.74B
6.38%-1.79B
-17.01%-674M
0
-1,656.36%-966M
Net issuance payments of debt
98.32%-23M
-10.54%-1.81B
--0
---451M
100.52%5M
---1.37B
3.53%-1.64B
-37.00%-685M
--0
---956M
Net other financing activities
109.57%36M
-124.67%-337M
263.64%40M
---2M
110.00%1M
-149.01%-376M
29.25%-150M
114.47%11M
----
81.82%-10M
Cash from discontinued financing activities
Financing cash flow
100.75%13M
-20.10%-2.15B
105.93%40M
---453M
100.62%6M
-1,054.97%-1.74B
6.38%-1.79B
-17.01%-674M
--0
-1,656.36%-966M
Net cash flow
Beginning cash position
7.76%3.56B
2.26%3.3B
-33.62%2.2B
-4.30%2.16B
-43.26%1.7B
2.26%3.3B
13.87%3.23B
47.51%3.32B
-15.43%2.26B
37.45%2.99B
Current changes in cash
112.26%202M
-4.86%235M
1,236.27%1.36B
-94.69%51M
168.57%469M
-1,148.48%-1.65B
-41.61%247M
-88.78%102M
348.32%961M
-219.79%-684M
Effect of exchange rate changes
-137.78%-17M
112.07%21M
91.74%-10M
-109.00%-9M
89.80%-5M
143.27%45M
-480.00%-174M
-277.94%-121M
403.03%100M
36.36%-49M
End cash Position
120.45%3.74B
7.76%3.56B
7.76%3.56B
-33.62%2.2B
-4.30%2.16B
-43.26%1.7B
2.26%3.3B
2.26%3.3B
47.51%3.32B
-15.43%2.26B
Free cash flow
10.34%-208M
53.27%1.15B
127.80%1.02B
-57.25%233M
2,083.33%131M
6.45%-232M
-11.05%749M
-58.12%446M
478.47%545M
-97.07%6M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 61.90%-40M32.24%1.65B101.39%1.16B-46.68%369M118.27%227M15.32%-105M-8.85%1.25B-51.44%575M13,740.00%692M-67.90%104M
Net income from continuing operations 67.73%369M172.38%1.42B274.91%481M211.28%434M132.38%283M152.51%220M-218.54%-1.96B-158.89%-275M-606.49%-390M3.53%-874M
Operating gains losses -500.00%-8M-------------100.00%-2M--2M46.34%-22M--0-600.00%-21M96.67%-1M
Depreciation and amortization -2.05%239M-5.38%1B-3.35%260M-3.86%249M-3.09%251M-10.29%244M-8.15%1.06B1.13%269M-8.48%259M-13.67%259M
Deferred tax -178.57%-22M-5.84%-671M-1,959.38%-595M301.89%107M50.24%-211M114.81%28M-100.00%-634M0.00%32M73.37%-53M-863.64%-424M
Other non cash items -440.00%-54M-85.54%81M-10.81%-41M800.00%27M-82.23%105M-600.00%-10M818.03%560M-186.05%-37M160.00%3M5,025.00%591M
Change In working capital 11.86%-617M-214.02%-1.37B193.47%229M-276.97%-561M-3,260.00%-336M-40.85%-700M-504.17%-435M-183.90%-245M239.65%317M-104.72%-10M
-Change in receivables -----170.61%-173M----------------1,941.67%245M------------
-Change in inventory -----8.43%152M----------------212.93%166M------------
-Change in payables and accrued expense -----105.81%-15M-----------------83.75%258M------------
-Change in other current assets -----20.47%-1.33B----------------27.61%-1.1B------------
Cash from discontinued investing activities
Operating cash flow 61.90%-40M32.24%1.65B101.39%1.16B-46.75%369M120.39%227M15.32%-105M-8.85%1.25B-51.44%575M13,760.00%693M-68.21%103M
Investing cash flow
Cash flow from continuing investing activities 13.93%229M-6.94%737M-18.32%165M-49.63%135M32.58%236M39.58%201M-18.18%792M-32.89%202M45.65%268M-41.06%178M
Net PPE purchase and sale -32.28%-168M-0.60%-501M-10.08%-142M8.11%-136M1.03%-96M-2.42%-127M5.32%-498M-8.40%-129M0.67%-148M18.49%-97M
Net business purchase and sale 147.06%42M21.43%34M--0-78.95%8M800.00%9M213.33%17M-58.82%28M--4M280.00%38M-98.21%1M
Net investment purchase and sale --051.61%-15M266.67%25M-133.33%-13M62.79%-16M8.33%-11M32.61%-31M-650.00%-15M202.63%39M-2,050.00%-43M
Net other investing changes --1M150.00%5M--0--2M--3M----140.00%2M------------
Cash from discontinued investing activities
Investing cash flow 13.93%229M-6.94%737M-18.32%165M-49.63%135M32.58%236M39.58%201M-18.18%792M-32.89%202M45.65%268M-41.06%178M
Financing cash flow
Cash flow from continuing financing activities 100.75%13M-20.10%-2.15B105.93%40M-453M100.62%6M-1,054.30%-1.74B6.38%-1.79B-17.01%-674M0-1,656.36%-966M
Net issuance payments of debt 98.32%-23M-10.54%-1.81B--0---451M100.52%5M---1.37B3.53%-1.64B-37.00%-685M--0---956M
Net other financing activities 109.57%36M-124.67%-337M263.64%40M---2M110.00%1M-149.01%-376M29.25%-150M114.47%11M----81.82%-10M
Cash from discontinued financing activities
Financing cash flow 100.75%13M-20.10%-2.15B105.93%40M---453M100.62%6M-1,054.97%-1.74B6.38%-1.79B-17.01%-674M--0-1,656.36%-966M
Net cash flow
Beginning cash position 7.76%3.56B2.26%3.3B-33.62%2.2B-4.30%2.16B-43.26%1.7B2.26%3.3B13.87%3.23B47.51%3.32B-15.43%2.26B37.45%2.99B
Current changes in cash 112.26%202M-4.86%235M1,236.27%1.36B-94.69%51M168.57%469M-1,148.48%-1.65B-41.61%247M-88.78%102M348.32%961M-219.79%-684M
Effect of exchange rate changes -137.78%-17M112.07%21M91.74%-10M-109.00%-9M89.80%-5M143.27%45M-480.00%-174M-277.94%-121M403.03%100M36.36%-49M
End cash Position 120.45%3.74B7.76%3.56B7.76%3.56B-33.62%2.2B-4.30%2.16B-43.26%1.7B2.26%3.3B2.26%3.3B47.51%3.32B-15.43%2.26B
Free cash flow 10.34%-208M53.27%1.15B127.80%1.02B-57.25%233M2,083.33%131M6.45%-232M-11.05%749M-58.12%446M478.47%545M-97.07%6M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More